左旋多巴与苄丝肼缓释制剂（美多芭HBS）治疗帕金森病的单剂量研究。 - Suppr | 超能文献

Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.

作者信息

Marion M H, Stocchi F, Quinn N P, Jenner P, Marsden C D

出版信息

Adv Neurol. 1987;45:493-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.左旋多巴与苄丝肼缓释制剂（美多芭HBS）治疗帕金森病的单剂量研究。

Adv Neurol. 1987;45:493-6.

2

Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.左旋多巴与苄丝肼缓释制剂（美多芭缓释片）治疗帕金森病的单剂量研究。

Eur Neurol. 1987;27 Suppl 1:54-8. doi: 10.1159/000116193.

3

Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.左旋多巴/苄丝肼双相释放剂型（Madopar HBS）用于帕金森病伴运动波动住院患者的临床及药代动力学观察

Eur Neurol. 1987;27 Suppl 1:93-7.

4

Madopar HBS in fluctuating parkinsonian patients: two-year treatment.美多芭HBS治疗帕金森病症状波动患者：两年治疗期

Mov Disord. 1988;3(1):37-45. doi: 10.1002/mds.870030106.

5

A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group.美多芭控释片与标准美多芭治疗帕金森病夜间及清晨功能障碍的比较。英国美多芭控释片研究小组。

Clin Neuropharmacol. 1989 Dec;12(6):498-505.

6

Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.老年帕金森病：左旋多巴/苄丝肼联合治疗的长期疗效研究

Pharmatherapeutica. 1986;4(9):571-6.

7

Open study of sustained-release formulation of levodopa and benserazide in parkinsonian patients.左旋多巴与苄丝肼缓释制剂治疗帕金森病患者的开放性研究。

Neurologija. 1990;39(2):99-105.

8

[Levodopa and decarboxylase inhibitors in Parkinson's disease].[左旋多巴与脱羧酶抑制剂治疗帕金森病]

Lakartidningen. 1977 Jan 5;74(1-2):37-40.

9

Treatment of early Parkinson's disease with controlled-release levodopa preparations.用控释左旋多巴制剂治疗早期帕金森病。

Neurology. 1989 Nov;39(11 Suppl 2):78-81; discussion 95.

10

[Controlled release levodopa-benserazide and changes in efficacy during treatment of Parkinson's disease].[左旋多巴-苄丝肼控释制剂与帕金森病治疗期间疗效的变化]

Rev Neurol (Paris). 1987;143(11):746-52.

引用本文的文献

1

Sustained-release of levodopa: single dose study of a new formulation.左旋多巴缓释剂：一种新剂型的单剂量研究

J Neural Transm (Vienna). 1996;103(6):717-27. doi: 10.1007/BF01271231.

2

A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease.控释左旋多巴（美多芭CR）与传统左旋多巴对晚期帕金森病疗效的比较。

J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):220-3. doi: 10.1136/jnnp.53.3.220.